Skip to main content

#152745

Anti-JMJD4 [JMJD4/32b/H12]

Cat. #152745

Anti-JMJD4 [JMJD4/32b/H12]

Cat. #: 152745

Unit size: 100 ug

Availability: 3-4 weeks

Target: Human Jmjd4

Class: Monoclonal

Application: ELISA ; IHC ; IP ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Helen Turley

Institute: University of Oxford

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-JMJD4 [JMJD4/32b/H12]
  • Research fields: Genetics
  • Clone: JMJD4/32b/H12
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Reactivity: Human
  • Host: Mouse
  • Application: ELISA ; IHC ; IP ; WB
  • Description: The anti-JMJD4 [JMJD4/32b/H12] antibody was raised against human Jmjd4. Jmjd4 is amplified/overexpressed at the level of gene, mRNA and protein in tumour cells.
  • Immunogen: Recombinant protein
  • Isotype: Not Known
  • Myeloma used: NS0
  • Recommended controls: HEK293 cells, cytoplasmic

Target Details

  • Target: Human Jmjd4
  • Target background: The anti-JMJD4 [JMJD4/32b/H12] antibody was raised against human Jmjd4. Jmjd4 is amplified/overexpressed at the level of gene, mRNA and protein in tumour cells.

Applications

  • Application: ELISA ; IHC ; IP ; WB

Handling

  • Format: Liquid
  • Concentration: 1mg/ml
  • Unit size: 100 ug
  • Storage buffer: RPMI 10% FCS plus HAT essential
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Dry ice

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.